nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP3A4—Temozolomide—malignant glioma	0.39	1	CbGbCtD
Letrozole—Anxiety depression—Temozolomide—malignant glioma	0.0315	0.0678	CcSEcCtD
Letrozole—Hemiparesis—Temozolomide—malignant glioma	0.0247	0.0531	CcSEcCtD
Letrozole—Leg edema—Temozolomide—malignant glioma	0.0192	0.0413	CcSEcCtD
Letrozole—Cerebral infarction—Carmustine—malignant glioma	0.0164	0.0354	CcSEcCtD
Letrozole—CYP2A6—Nicotine Metabolism—CYP2B6—malignant glioma	0.0119	0.0873	CbGpPWpGaD
Letrozole—Transient ischaemic attack—Temozolomide—malignant glioma	0.0102	0.0221	CcSEcCtD
Letrozole—Cerebral haemorrhage—Carmustine—malignant glioma	0.00966	0.0208	CcSEcCtD
Letrozole—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00934	0.0201	CcSEcCtD
Letrozole—Bifonazole—CYP2B6—malignant glioma	0.00895	1	CrCbGaD
Letrozole—Embolism—Temozolomide—malignant glioma	0.00805	0.0173	CcSEcCtD
Letrozole—Cyst—Carmustine—malignant glioma	0.008	0.0172	CcSEcCtD
Letrozole—CYP2A6—CYP2E1 reactions—CYP2B6—malignant glioma	0.00735	0.0538	CbGpPWpGaD
Letrozole—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00698	0.015	CcSEcCtD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—POR—malignant glioma	0.00674	0.0493	CbGpPWpGaD
Letrozole—Memory impairment—Temozolomide—malignant glioma	0.00659	0.0142	CcSEcCtD
Letrozole—Breast pain—Temozolomide—malignant glioma	0.00592	0.0128	CcSEcCtD
Letrozole—Viral infection—Temozolomide—malignant glioma	0.00572	0.0123	CcSEcCtD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—POR—malignant glioma	0.00536	0.0392	CbGpPWpGaD
Letrozole—Pulmonary embolism—Carmustine—malignant glioma	0.00535	0.0115	CcSEcCtD
Letrozole—Musculoskeletal pain—Temozolomide—malignant glioma	0.00523	0.0113	CcSEcCtD
Letrozole—Pulmonary embolism—Temozolomide—malignant glioma	0.00517	0.0111	CcSEcCtD
Letrozole—Neoplasm—Carmustine—malignant glioma	0.00484	0.0104	CcSEcCtD
Letrozole—Neoplasm—Temozolomide—malignant glioma	0.00467	0.0101	CcSEcCtD
Letrozole—CYP2A6—Xenobiotics—CYP2B6—malignant glioma	0.00455	0.0333	CbGpPWpGaD
Letrozole—Phlebitis—Carmustine—malignant glioma	0.00451	0.00971	CcSEcCtD
Letrozole—Thrombophlebitis—Carmustine—malignant glioma	0.00449	0.00966	CcSEcCtD
Letrozole—Thrombophlebitis—Temozolomide—malignant glioma	0.00433	0.00934	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—AREG—malignant glioma	0.00427	0.0312	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—ASMT—malignant glioma	0.00412	0.0302	CbGpPWpGaD
Letrozole—Hot flush—Temozolomide—malignant glioma	0.00401	0.00864	CcSEcCtD
Letrozole—Menopausal symptoms—Temozolomide—malignant glioma	0.00398	0.00857	CcSEcCtD
Letrozole—CYP2A6—Xenobiotics—CYP2C18—malignant glioma	0.00395	0.0289	CbGpPWpGaD
Letrozole—Thirst—Temozolomide—malignant glioma	0.00394	0.00849	CcSEcCtD
Letrozole—Dry skin—Temozolomide—malignant glioma	0.00344	0.00741	CcSEcCtD
Letrozole—Breast disorder—Temozolomide—malignant glioma	0.00339	0.0073	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00338	0.00728	CcSEcCtD
Letrozole—Sweating increased—Temozolomide—malignant glioma	0.00316	0.0068	CcSEcCtD
Letrozole—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00313	0.0229	CbGpPWpGaD
Letrozole—Pollakiuria—Temozolomide—malignant glioma	0.003	0.00645	CcSEcCtD
Letrozole—Depression—Carmustine—malignant glioma	0.00298	0.00643	CcSEcCtD
Letrozole—Weight increased—Temozolomide—malignant glioma	0.00295	0.00636	CcSEcCtD
Letrozole—Weight decreased—Temozolomide—malignant glioma	0.00293	0.00632	CcSEcCtD
Letrozole—Stomatitis—Carmustine—malignant glioma	0.00292	0.00628	CcSEcCtD
Letrozole—Urinary tract infection—Carmustine—malignant glioma	0.00291	0.00627	CcSEcCtD
Letrozole—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00291	0.0213	CbGpPWpGaD
Letrozole—Infestation NOS—Temozolomide—malignant glioma	0.00289	0.00623	CcSEcCtD
Letrozole—Infestation—Temozolomide—malignant glioma	0.00289	0.00623	CcSEcCtD
Letrozole—Depression—Temozolomide—malignant glioma	0.00288	0.00621	CcSEcCtD
Letrozole—Stomatitis—Temozolomide—malignant glioma	0.00282	0.00607	CcSEcCtD
Letrozole—Urinary tract infection—Temozolomide—malignant glioma	0.00281	0.00605	CcSEcCtD
Letrozole—Hepatobiliary disease—Temozolomide—malignant glioma	0.00273	0.00589	CcSEcCtD
Letrozole—Haemoglobin—Carmustine—malignant glioma	0.0027	0.00582	CcSEcCtD
Letrozole—Haemorrhage—Carmustine—malignant glioma	0.00269	0.00579	CcSEcCtD
Letrozole—Hypoaesthesia—Carmustine—malignant glioma	0.00267	0.00576	CcSEcCtD
Letrozole—Oedema peripheral—Carmustine—malignant glioma	0.00265	0.0057	CcSEcCtD
Letrozole—Connective tissue disorder—Carmustine—malignant glioma	0.00264	0.00569	CcSEcCtD
Letrozole—Haemoglobin—Temozolomide—malignant glioma	0.00261	0.00562	CcSEcCtD
Letrozole—Haemorrhage—Temozolomide—malignant glioma	0.0026	0.00559	CcSEcCtD
Letrozole—Hepatitis—Temozolomide—malignant glioma	0.0026	0.00559	CcSEcCtD
Letrozole—Hypoaesthesia—Temozolomide—malignant glioma	0.00258	0.00556	CcSEcCtD
Letrozole—Urinary tract disorder—Temozolomide—malignant glioma	0.00256	0.00552	CcSEcCtD
Letrozole—Oedema peripheral—Temozolomide—malignant glioma	0.00256	0.00551	CcSEcCtD
Letrozole—Connective tissue disorder—Temozolomide—malignant glioma	0.00255	0.00549	CcSEcCtD
Letrozole—CYP19A1—Tryptophan metabolism—CYP2C18—malignant glioma	0.00255	0.0186	CbGpPWpGaD
Letrozole—Urethral disorder—Temozolomide—malignant glioma	0.00254	0.00548	CcSEcCtD
Letrozole—Eye disorder—Carmustine—malignant glioma	0.00251	0.00541	CcSEcCtD
Letrozole—Flushing—Carmustine—malignant glioma	0.00249	0.00537	CcSEcCtD
Letrozole—Erythema multiforme—Temozolomide—malignant glioma	0.00245	0.00529	CcSEcCtD
Letrozole—Eye disorder—Temozolomide—malignant glioma	0.00243	0.00523	CcSEcCtD
Letrozole—Flushing—Temozolomide—malignant glioma	0.00241	0.00519	CcSEcCtD
Letrozole—Cardiac disorder—Temozolomide—malignant glioma	0.00241	0.00519	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00238	0.0174	CbGpPWpGaD
Letrozole—Alopecia—Carmustine—malignant glioma	0.00237	0.00511	CcSEcCtD
Letrozole—Angiopathy—Temozolomide—malignant glioma	0.00235	0.00507	CcSEcCtD
Letrozole—Mental disorder—Carmustine—malignant glioma	0.00235	0.00507	CcSEcCtD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00234	0.0172	CbGpPWpGaD
Letrozole—Mediastinal disorder—Temozolomide—malignant glioma	0.00234	0.00504	CcSEcCtD
Letrozole—Malnutrition—Carmustine—malignant glioma	0.00234	0.00504	CcSEcCtD
Letrozole—Alopecia—Temozolomide—malignant glioma	0.00229	0.00494	CcSEcCtD
Letrozole—Mental disorder—Temozolomide—malignant glioma	0.00227	0.0049	CcSEcCtD
Letrozole—Back pain—Carmustine—malignant glioma	0.00226	0.00487	CcSEcCtD
Letrozole—Malnutrition—Temozolomide—malignant glioma	0.00226	0.00487	CcSEcCtD
Letrozole—Dysgeusia—Temozolomide—malignant glioma	0.00221	0.00477	CcSEcCtD
Letrozole—Vision blurred—Carmustine—malignant glioma	0.0022	0.00475	CcSEcCtD
Letrozole—Back pain—Temozolomide—malignant glioma	0.00219	0.00471	CcSEcCtD
Letrozole—Vision blurred—Temozolomide—malignant glioma	0.00213	0.00459	CcSEcCtD
Letrozole—Ill-defined disorder—Temozolomide—malignant glioma	0.0021	0.00452	CcSEcCtD
Letrozole—Leukopenia—Carmustine—malignant glioma	0.00209	0.00451	CcSEcCtD
Letrozole—Angioedema—Temozolomide—malignant glioma	0.00206	0.00445	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00206	0.0151	CbGpPWpGaD
Letrozole—Malaise—Temozolomide—malignant glioma	0.00204	0.00439	CcSEcCtD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00203	0.0149	CbGpPWpGaD
Letrozole—Vertigo—Temozolomide—malignant glioma	0.00203	0.00437	CcSEcCtD
Letrozole—Leukopenia—Temozolomide—malignant glioma	0.00202	0.00436	CcSEcCtD
Letrozole—Hypertension—Carmustine—malignant glioma	0.00202	0.00435	CcSEcCtD
Letrozole—Palpitations—Temozolomide—malignant glioma	0.002	0.0043	CcSEcCtD
Letrozole—Myalgia—Carmustine—malignant glioma	0.00199	0.00429	CcSEcCtD
Letrozole—Chest pain—Carmustine—malignant glioma	0.00199	0.00429	CcSEcCtD
Letrozole—Anxiety—Carmustine—malignant glioma	0.00198	0.00427	CcSEcCtD
Letrozole—Cough—Temozolomide—malignant glioma	0.00197	0.00425	CcSEcCtD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00197	0.0144	CbGpPWpGaD
Letrozole—Hypertension—Temozolomide—malignant glioma	0.00195	0.0042	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00193	0.0141	CbGpPWpGaD
Letrozole—Myalgia—Temozolomide—malignant glioma	0.00192	0.00414	CcSEcCtD
Letrozole—Arthralgia—Temozolomide—malignant glioma	0.00192	0.00414	CcSEcCtD
Letrozole—Anxiety—Temozolomide—malignant glioma	0.00192	0.00413	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00191	0.00412	CcSEcCtD
Letrozole—Oedema—Carmustine—malignant glioma	0.00191	0.00411	CcSEcCtD
Letrozole—Discomfort—Temozolomide—malignant glioma	0.0019	0.00409	CcSEcCtD
Letrozole—Infection—Carmustine—malignant glioma	0.0019	0.00408	CcSEcCtD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00189	0.0138	CbGpPWpGaD
Letrozole—Dry mouth—Temozolomide—malignant glioma	0.00188	0.00405	CcSEcCtD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00187	0.0137	CbGpPWpGaD
Letrozole—Tachycardia—Carmustine—malignant glioma	0.00186	0.00401	CcSEcCtD
Letrozole—Oedema—Temozolomide—malignant glioma	0.00184	0.00397	CcSEcCtD
Letrozole—Anaphylactic shock—Temozolomide—malignant glioma	0.00184	0.00397	CcSEcCtD
Letrozole—Infection—Temozolomide—malignant glioma	0.00183	0.00395	CcSEcCtD
Letrozole—Anorexia—Carmustine—malignant glioma	0.00182	0.00392	CcSEcCtD
Letrozole—Nervous system disorder—Temozolomide—malignant glioma	0.00181	0.0039	CcSEcCtD
Letrozole—Skin disorder—Temozolomide—malignant glioma	0.00179	0.00386	CcSEcCtD
Letrozole—Hyperhidrosis—Temozolomide—malignant glioma	0.00178	0.00384	CcSEcCtD
Letrozole—Anorexia—Temozolomide—malignant glioma	0.00176	0.00379	CcSEcCtD
Letrozole—CYP19A1—Ovarian Infertility Genes—NCOR1—malignant glioma	0.00175	0.0128	CbGpPWpGaD
Letrozole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00174	0.00375	CcSEcCtD
Letrozole—Insomnia—Carmustine—malignant glioma	0.00173	0.00372	CcSEcCtD
Letrozole—Paraesthesia—Carmustine—malignant glioma	0.00171	0.00369	CcSEcCtD
Letrozole—Dyspnoea—Carmustine—malignant glioma	0.0017	0.00366	CcSEcCtD
Letrozole—Somnolence—Carmustine—malignant glioma	0.0017	0.00365	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00168	0.00362	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00167	0.0122	CbGpPWpGaD
Letrozole—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00167	0.0122	CbGpPWpGaD
Letrozole—Insomnia—Temozolomide—malignant glioma	0.00167	0.00359	CcSEcCtD
Letrozole—Decreased appetite—Carmustine—malignant glioma	0.00166	0.00357	CcSEcCtD
Letrozole—Paraesthesia—Temozolomide—malignant glioma	0.00166	0.00357	CcSEcCtD
Letrozole—Gastrointestinal disorder—Carmustine—malignant glioma	0.00165	0.00355	CcSEcCtD
Letrozole—Dyspnoea—Temozolomide—malignant glioma	0.00164	0.00354	CcSEcCtD
Letrozole—Somnolence—Temozolomide—malignant glioma	0.00164	0.00353	CcSEcCtD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00164	0.012	CbGpPWpGaD
Letrozole—Constipation—Carmustine—malignant glioma	0.00163	0.00352	CcSEcCtD
Letrozole—Pain—Carmustine—malignant glioma	0.00163	0.00352	CcSEcCtD
Letrozole—Dyspepsia—Temozolomide—malignant glioma	0.00162	0.0035	CcSEcCtD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00162	0.0118	CbGpPWpGaD
Letrozole—Decreased appetite—Temozolomide—malignant glioma	0.0016	0.00345	CcSEcCtD
Letrozole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00159	0.00343	CcSEcCtD
Letrozole—Fatigue—Temozolomide—malignant glioma	0.00159	0.00342	CcSEcCtD
Letrozole—Pain—Temozolomide—malignant glioma	0.00158	0.0034	CcSEcCtD
Letrozole—Constipation—Temozolomide—malignant glioma	0.00158	0.0034	CcSEcCtD
Letrozole—Feeling abnormal—Carmustine—malignant glioma	0.00157	0.00339	CcSEcCtD
Letrozole—Gastrointestinal pain—Carmustine—malignant glioma	0.00156	0.00336	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00153	0.0112	CbGpPWpGaD
Letrozole—Feeling abnormal—Temozolomide—malignant glioma	0.00152	0.00327	CcSEcCtD
Letrozole—Body temperature increased—Carmustine—malignant glioma	0.00151	0.00325	CcSEcCtD
Letrozole—Abdominal pain—Carmustine—malignant glioma	0.00151	0.00325	CcSEcCtD
Letrozole—Gastrointestinal pain—Temozolomide—malignant glioma	0.00151	0.00325	CcSEcCtD
Letrozole—Urticaria—Temozolomide—malignant glioma	0.00146	0.00316	CcSEcCtD
Letrozole—Abdominal pain—Temozolomide—malignant glioma	0.00146	0.00314	CcSEcCtD
Letrozole—Body temperature increased—Temozolomide—malignant glioma	0.00146	0.00314	CcSEcCtD
Letrozole—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00145	0.0106	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—FTH1—malignant glioma	0.0014	0.0103	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—CAT—malignant glioma	0.00139	0.0102	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—malignant glioma	0.00137	0.01	CbGpPWpGaD
Letrozole—Asthenia—Carmustine—malignant glioma	0.00137	0.00295	CcSEcCtD
Letrozole—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00136	0.00993	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00133	0.00972	CbGpPWpGaD
Letrozole—Asthenia—Temozolomide—malignant glioma	0.00132	0.00285	CcSEcCtD
Letrozole—Diarrhoea—Carmustine—malignant glioma	0.00131	0.00281	CcSEcCtD
Letrozole—Pruritus—Temozolomide—malignant glioma	0.0013	0.00281	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00127	0.00926	CbGpPWpGaD
Letrozole—Dizziness—Carmustine—malignant glioma	0.00126	0.00272	CcSEcCtD
Letrozole—Diarrhoea—Temozolomide—malignant glioma	0.00126	0.00272	CcSEcCtD
Letrozole—Dizziness—Temozolomide—malignant glioma	0.00122	0.00263	CcSEcCtD
Letrozole—Vomiting—Carmustine—malignant glioma	0.00121	0.00261	CcSEcCtD
Letrozole—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.0012	0.0088	CbGpPWpGaD
Letrozole—Rash—Carmustine—malignant glioma	0.0012	0.00259	CcSEcCtD
Letrozole—Dermatitis—Carmustine—malignant glioma	0.0012	0.00259	CcSEcCtD
Letrozole—Headache—Carmustine—malignant glioma	0.0012	0.00258	CcSEcCtD
Letrozole—Vomiting—Temozolomide—malignant glioma	0.00117	0.00253	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—RAF1—malignant glioma	0.00117	0.00857	CbGpPWpGaD
Letrozole—Rash—Temozolomide—malignant glioma	0.00116	0.0025	CcSEcCtD
Letrozole—Dermatitis—Temozolomide—malignant glioma	0.00116	0.0025	CcSEcCtD
Letrozole—Headache—Temozolomide—malignant glioma	0.00116	0.00249	CcSEcCtD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00115	0.00839	CbGpPWpGaD
Letrozole—Nausea—Carmustine—malignant glioma	0.00113	0.00244	CcSEcCtD
Letrozole—Nausea—Temozolomide—malignant glioma	0.0011	0.00236	CcSEcCtD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00109	0.00799	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—malignant glioma	0.00108	0.0079	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP2B6—malignant glioma	0.00102	0.00749	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00101	0.00738	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00101	0.00737	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.000984	0.0072	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.000965	0.00706	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP2C18—malignant glioma	0.000887	0.00649	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.000875	0.0064	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.000873	0.00639	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—PML—malignant glioma	0.000816	0.00597	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP2B6—malignant glioma	0.000814	0.00596	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—MDM2—malignant glioma	0.000767	0.00562	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000743	0.00544	CbGpPWpGaD
Letrozole—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000736	0.00539	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTT1—malignant glioma	0.000717	0.00525	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP2C18—malignant glioma	0.000706	0.00517	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000693	0.00507	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000684	0.00501	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—PTGS1—malignant glioma	0.000672	0.00492	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000601	0.0044	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000593	0.00434	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GSTT1—malignant glioma	0.000571	0.00418	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—AKT1—malignant glioma	0.000569	0.00417	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000562	0.00411	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SLC5A5—malignant glioma	0.00056	0.0041	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.000539	0.00395	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—PTGS1—malignant glioma	0.000535	0.00391	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SLC6A3—malignant glioma	0.000533	0.0039	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—RTEL1—malignant glioma	0.000503	0.00368	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTP1—malignant glioma	0.000497	0.00364	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—GSTP1—malignant glioma	0.00049	0.00359	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000487	0.00357	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TP53—malignant glioma	0.000457	0.00335	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTP1—malignant glioma	0.000451	0.0033	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000405	0.00297	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—RTEL1—malignant glioma	0.0004	0.00293	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GSTP1—malignant glioma	0.000396	0.0029	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.000389	0.00284	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000369	0.0027	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000359	0.00263	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—PDGFB—malignant glioma	0.000357	0.00261	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.000354	0.00259	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00035	0.00256	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000348	0.00254	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.000301	0.0022	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000298	0.00218	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.000296	0.00217	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000294	0.00215	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—COX8A—malignant glioma	0.000289	0.00211	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000265	0.00194	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000259	0.00189	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000258	0.00189	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000255	0.00187	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000249	0.00182	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ASMT—malignant glioma	0.000245	0.0018	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00024	0.00176	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—BCAN—malignant glioma	0.000231	0.00169	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—COX8A—malignant glioma	0.00023	0.00168	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000225	0.00165	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000224	0.00164	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000209	0.00153	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000207	0.00152	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000203	0.00148	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000196	0.00144	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ASMT—malignant glioma	0.000195	0.00143	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000191	0.0014	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—IDH2—malignant glioma	0.000186	0.00136	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—BCAN—malignant glioma	0.000184	0.00134	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000175	0.00128	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2B6—malignant glioma	0.000175	0.00128	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.00017	0.00124	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—IDH1—malignant glioma	0.00016	0.00117	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SPHK1—malignant glioma	0.000155	0.00113	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2C18—malignant glioma	0.000152	0.00111	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—IDH2—malignant glioma	0.000148	0.00108	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000147	0.00107	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000145	0.00106	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000144	0.00105	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000143	0.00105	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000143	0.00105	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2B6—malignant glioma	0.000139	0.00102	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00013	0.000953	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—IDH1—malignant glioma	0.000127	0.000932	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000126	0.00092	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SPHK1—malignant glioma	0.000123	0.000902	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTT1—malignant glioma	0.000123	0.000898	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2C18—malignant glioma	0.000121	0.000883	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS1—malignant glioma	0.000115	0.000841	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000115	0.000838	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—BCHE—malignant glioma	0.000107	0.000782	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC5A5—malignant glioma	0.000106	0.000772	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.98e-05	0.00073	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.89e-05	0.000724	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTT1—malignant glioma	9.76e-05	0.000714	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS1—malignant glioma	9.15e-05	0.000669	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.63e-05	0.000631	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—BCHE—malignant glioma	8.51e-05	0.000622	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTP1—malignant glioma	8.5e-05	0.000622	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—COX8A—malignant glioma	8.43e-05	0.000617	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC5A5—malignant glioma	8.4e-05	0.000615	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAT—malignant glioma	8.27e-05	0.000605	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NCOR1—malignant glioma	7.81e-05	0.000572	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ASMT—malignant glioma	7.16e-05	0.000524	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTP1—malignant glioma	6.77e-05	0.000495	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BCAN—malignant glioma	6.74e-05	0.000493	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAT—malignant glioma	6.58e-05	0.000482	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAV1—malignant glioma	6.37e-05	0.000466	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOR1—malignant glioma	6.22e-05	0.000455	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.08e-05	0.000445	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CG—malignant glioma	5.8e-05	0.000425	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARG—malignant glioma	5.6e-05	0.00041	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—IDH2—malignant glioma	5.43e-05	0.000397	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.1e-05	0.000374	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CD—malignant glioma	5.1e-05	0.000373	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAV1—malignant glioma	5.07e-05	0.000371	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—IDH1—malignant glioma	4.67e-05	0.000342	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CG—malignant glioma	4.62e-05	0.000338	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SPHK1—malignant glioma	4.52e-05	0.000331	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARG—malignant glioma	4.46e-05	0.000326	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CB—malignant glioma	4.45e-05	0.000325	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.43e-05	0.000324	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—malignant glioma	4.4e-05	0.000322	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CD—malignant glioma	4.06e-05	0.000297	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTEN—malignant glioma	3.84e-05	0.000281	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTT1—malignant glioma	3.58e-05	0.000262	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CB—malignant glioma	3.54e-05	0.000259	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—malignant glioma	3.51e-05	0.000257	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS1—malignant glioma	3.35e-05	0.000245	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BCHE—malignant glioma	3.12e-05	0.000228	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.08e-05	0.000225	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTEN—malignant glioma	3.06e-05	0.000224	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CA—malignant glioma	2.71e-05	0.000198	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTP1—malignant glioma	2.48e-05	0.000182	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAT—malignant glioma	2.41e-05	0.000177	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOR1—malignant glioma	2.28e-05	0.000167	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—malignant glioma	2.21e-05	0.000162	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CA—malignant glioma	2.16e-05	0.000158	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAV1—malignant glioma	1.86e-05	0.000136	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—malignant glioma	1.76e-05	0.000129	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.69e-05	0.000124	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARG—malignant glioma	1.63e-05	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.49e-05	0.000109	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.3e-05	9.49e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—malignant glioma	1.29e-05	9.41e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTEN—malignant glioma	1.12e-05	8.2e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.91e-06	5.79e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—malignant glioma	6.46e-06	4.73e-05	CbGpPWpGaD
